• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

KDR/Flk-1(血管内皮生长因子受体-2)的230 kDa成熟形式激活PLC-γ途径,并在NIH3T3成纤维细胞中部分诱导有丝分裂信号。

The 230 kDa mature form of KDR/Flk-1 (VEGF receptor-2) activates the PLC-gamma pathway and partially induces mitotic signals in NIH3T3 fibroblasts.

作者信息

Takahashi T, Shibuya M

机构信息

Department of Genetics, Institute of Medical Science, University of Tokyo, Minato-ku, Japan.

出版信息

Oncogene. 1997 May 1;14(17):2079-89. doi: 10.1038/sj.onc.1201047.

DOI:10.1038/sj.onc.1201047
PMID:9160888
Abstract

KDR/Flk-1 tyrosine kinase, one of the two receptors for Vascular Endothelial Growth Factor (VEGF) has been shown to generate the major part of mitotic signals in endothelial cells, although the mechanisms are poorly understood. Here we examined the processing and signal transduction of KDR/Flk-1. Both in endothelial cells and in NIH3T3 cells expressing KDR/Flk-1, an immature form of KDR/Flk-1 with a molecular mass of about 150 kDa was glycosylated to create a 200 kDa intermediate, and after further glycosylation a mature 230 kDa was expressed on the cell surface. Only this 230 kDa form was rapidly and transiently phosphorylated on tyrosine residues in the presence of VEGF. As a major substrate of KDR/Flk-1, PLC-gamma was found to be rapidly tyrosine-phosphorylated and associated with KDR/Flk-1 both in endothelial cells and NIH3T3 cells. Interestingly, however, a prompt activation of MAP kinase and subsequent strong mitotic signaling were generated only in the endothelial cell background. Activation of MAP kinase in NIH3T3 cells overexpressing KDR/Flk-1 showed a slower response as maximum levels were only attained after 20 min compared to 5 min in sinusoidal endothelial cells. These results suggest that the KDR/Flk-1 utilizes cell type-specific signal transduction pathway(s) for MAP kinase activation and the mitotic response in endothelial cells.

摘要

KDR/Flk-1酪氨酸激酶是血管内皮生长因子(VEGF)的两种受体之一,已被证明可在内皮细胞中产生大部分有丝分裂信号,尽管其机制尚不清楚。在此,我们研究了KDR/Flk-1的加工和信号转导。在内皮细胞和表达KDR/Flk-1的NIH3T3细胞中,分子量约为150 kDa的未成熟形式的KDR/Flk-1被糖基化形成200 kDa的中间体,进一步糖基化后,成熟的230 kDa形式在细胞表面表达。只有这种230 kDa的形式在VEGF存在下能迅速且短暂地在酪氨酸残基上磷酸化。作为KDR/Flk-1的主要底物,PLC-γ在内皮细胞和NIH3T3细胞中均被发现能迅速酪氨酸磷酸化并与KDR/Flk-1结合。然而,有趣的是,只有在内皮细胞背景下才会迅速激活MAP激酶并随后产生强烈的有丝分裂信号。过表达KDR/Flk-1的NIH3T3细胞中MAP激酶的激活显示出较慢的反应,因为与窦状内皮细胞中的5分钟相比,最大水平仅在20分钟后才能达到。这些结果表明,KDR/Flk-1利用细胞类型特异性信号转导途径来激活内皮细胞中的MAP激酶并引发有丝分裂反应。

相似文献

1
The 230 kDa mature form of KDR/Flk-1 (VEGF receptor-2) activates the PLC-gamma pathway and partially induces mitotic signals in NIH3T3 fibroblasts.KDR/Flk-1(血管内皮生长因子受体-2)的230 kDa成熟形式激活PLC-γ途径,并在NIH3T3成纤维细胞中部分诱导有丝分裂信号。
Oncogene. 1997 May 1;14(17):2079-89. doi: 10.1038/sj.onc.1201047.
2
A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells.KDR/Flk-1 上的单个自磷酸化位点对于血管内皮细胞中 VEGF-A 依赖的 PLC-γ 激活和 DNA 合成至关重要。
EMBO J. 2001 Jun 1;20(11):2768-78. doi: 10.1093/emboj/20.11.2768.
3
A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF.一种源自FLT酪氨酸激酶(血管内皮生长因子VEGF的受体)的独特信号转导。
Oncogene. 1995 Jan 5;10(1):135-47.
4
Vascular permeability factor/vascular endothelial growth factor-mediated signaling in mouse mesentery vascular endothelium.血管通透性因子/血管内皮生长因子介导的小鼠肠系膜血管内皮细胞信号传导
Cancer Res. 1998 Mar 15;58(6):1278-84.
5
Possible involvement of VEGF-FLT tyrosine kinase receptor system in normal and tumor angiogenesis.血管内皮生长因子-弗林蛋白酶酪氨酸激酶受体系统在正常及肿瘤血管生成中的可能作用。
Princess Takamatsu Symp. 1994;24:162-70.
6
A new communication system between hepatocytes and sinusoidal endothelial cells in liver through vascular endothelial growth factor and Flt tyrosine kinase receptor family (Flt-1 and KDR/Flk-1).一种通过血管内皮生长因子和Flt酪氨酸激酶受体家族(Flt-1和KDR/Flk-1)在肝脏中肝细胞与窦状内皮细胞之间建立的新型通讯系统。
Oncogene. 1994 Sep;9(9):2683-90.
7
Inhibition of vascular endothelial growth factor-induced receptor activation with anti-kinase insert domain-containing receptor single-chain antibodies from a phage display library.利用噬菌体展示文库中的抗含激酶插入结构域受体单链抗体抑制血管内皮生长因子诱导的受体激活。
Cancer Res. 1998 Aug 1;58(15):3209-14.
8
Placenta growth factor stimulates MAP kinase and mitogenicity but not phospholipase C-gamma and migration of endothelial cells expressing Flt 1.胎盘生长因子刺激丝裂原活化蛋白激酶和有丝分裂活性,但不刺激磷脂酶C-γ以及表达Flt 1的内皮细胞的迁移。
Oncogene. 1998 Jan 22;16(3):359-67. doi: 10.1038/sj.onc.1201545.
9
The adapter protein, Grb10, is a positive regulator of vascular endothelial growth factor signaling.衔接蛋白Grb10是血管内皮生长因子信号传导的正向调节因子。
Oncogene. 2001 Jul 5;20(30):3959-68. doi: 10.1038/sj.onc.1204520.
10
KDR/Flk-1 is a major regulator of vascular endothelial growth factor-induced tumor development and angiogenesis in murine hepatocellular carcinoma cells.KDR/Flk-1是血管内皮生长因子诱导的小鼠肝癌细胞肿瘤发展和血管生成的主要调节因子。
Hepatology. 1999 Nov;30(5):1179-86. doi: 10.1002/hep.510300509.

引用本文的文献

1
Targeting vascular endothelial growth receptor-2 (VEGFR-2): structural biology, functional insights, and therapeutic resistance.靶向血管内皮生长因子受体-2(VEGFR-2):结构生物学、功能见解及治疗抗性
Arch Pharm Res. 2025 May 8. doi: 10.1007/s12272-025-01545-1.
2
Contribution of VEGF-B-Induced Endocardial Endothelial Cell Lineage in Physiological Versus Pathological Cardiac Hypertrophy.VEGF-B 诱导的心内膜内皮细胞谱系在生理和病理性心肌肥厚中的作用。
Circ Res. 2024 May 24;134(11):1465-1482. doi: 10.1161/CIRCRESAHA.123.324136. Epub 2024 Apr 24.
3
VEGFA mRNA-LNP promotes biliary epithelial cell-to-hepatocyte conversion in acute and chronic liver diseases and reverses steatosis and fibrosis.
血管内皮生长因子A信使核糖核酸脂质纳米颗粒在急慢性肝病中促进胆管上皮细胞向肝细胞转化,并逆转脂肪变性和肝纤维化。
Cell Stem Cell. 2023 Dec 7;30(12):1640-1657.e8. doi: 10.1016/j.stem.2023.10.008. Epub 2023 Nov 28.
4
SGLT1 as an adverse prognostic factor in invasive ductal carcinoma of the breast.SGLT1 作为乳腺浸润性导管癌的不良预后因素。
Breast Cancer Res Treat. 2023 Oct;201(3):499-513. doi: 10.1007/s10549-023-07024-9. Epub 2023 Jul 13.
5
Therapeutic Potential of Chinese Medicine for Endogenous Neurogenesis: A Promising Candidate for Stroke Treatment.中药促进内源性神经发生的治疗潜力:中风治疗的一个有前景的候选方法。
Pharmaceuticals (Basel). 2023 May 7;16(5):706. doi: 10.3390/ph16050706.
6
Angiostatic freeze or angiogenic move? Acute cold stress prevents angiokine secretion from murine myotubes but primes primary endothelial cells for greater migratory capacity.血管生成抑制性冻结还是血管生成性迁移?急性冷应激会阻止小鼠肌管分泌血管生成素,但会使原代内皮细胞具备更强的迁移能力。
Front Physiol. 2022 Oct 17;13:975652. doi: 10.3389/fphys.2022.975652. eCollection 2022.
7
Protein post-translational modifications in the regulation of cancer hallmarks.蛋白质翻译后修饰在癌症特征调控中的作用
Cancer Gene Ther. 2023 Apr;30(4):529-547. doi: 10.1038/s41417-022-00464-3. Epub 2022 Apr 7.
8
Role of Glycans on Key Cell Surface Receptors That Regulate Cell Proliferation and Cell Death.糖链在调控细胞增殖和细胞死亡的关键细胞表面受体中的作用。
Cells. 2021 May 19;10(5):1252. doi: 10.3390/cells10051252.
9
VEGFR1 signaling in retinal angiogenesis and microinflammation.VEGFR1 信号在视网膜血管生成和微炎症中的作用。
Prog Retin Eye Res. 2021 Sep;84:100954. doi: 10.1016/j.preteyeres.2021.100954. Epub 2021 Feb 25.
10
Molecular Bases of VEGFR-2-Mediated Physiological Function and Pathological Role.VEGFR-2介导的生理功能和病理作用的分子基础
Front Cell Dev Biol. 2020 Nov 16;8:599281. doi: 10.3389/fcell.2020.599281. eCollection 2020.